Brown Ryan Edward's Form 4 filing
Sarepta Therapeutics, Inc. (SRPT) · filed Jun 25, 2024
- Accession no.
- 0000950170-24-077522
- Filed
- Jun 25, 2024
- Trade date
- Jun 21-25, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 10 non-derivative transactions and 4 derivative transactions. Open-market sales total $6.30M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Brown Ryan EdwardCIK 0001848718 | Officer (EVP, General Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 21, 2024 | Common Stock | MOption exerciseAcquired | +6,250 | – | – | 34,938 | Direct | |
| Jun 24, 2024 | Common Stock | FTax withholdingDisposed | −2,352 | $164.64 | −$387,233.28 | 32,586 | Direct | |
| Jun 25, 2024 | Common Stock | MOption exerciseAcquired | +23,500 | $62.77 | +$1,475,095 | 56,086 | Direct | |
| Jun 25, 2024 | Common Stock | SSaleDisposed | −7,644 | $158.07 | −$1,208,287.08 | 48,442 | Direct | |
| Jun 25, 2024 | Common Stock | SSaleDisposed | −2,200 | $159.14 | −$350,108 | 46,242 | Direct | |
| Jun 25, 2024 | Common Stock | SSaleDisposed | −975 | $160.31 | −$156,302.25 | 45,267 | Direct | |
| Jun 25, 2024 | Common Stock | SSaleDisposed | −4,168 | $161.82 | −$674,465.76 | 41,099 | Direct | |
| Jun 25, 2024 | Common Stock | SSaleDisposed | −17,581 | $162.65 | −$2,859,549.65 | 23,518 | Direct | |
| Jun 25, 2024 | Common Stock | SSaleDisposed | −3,840 | $163.53 | −$627,955.2 | 19,678 | Direct | |
| Jun 25, 2024 | Common Stock | SSaleDisposed | −2,549 | $164.52 | −$419,361.48 | 17,129 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 21, 2024 | Common Stock | AGrant or awardAcquired | +5,500 | $0.00 | $0 | 5,500 | Direct | |
| Jun 21, 2024 | Common Stock | AGrant or awardAcquired | +6,250 | $0.00 | $0 | 6,250 | Direct | |
| Jun 21, 2024 | Common Stock | MOption exerciseDisposed | −6,250 | $0.00 | $0 | 0 | Direct | |
| Jun 25, 2024 | Common Stock | MOption exerciseDisposed | −23,500 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.